Figures computed from official regulatory filings — .
Statistical track record
Free accountWin rates, median returns and the proven-insider analysis come with a free account.
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
GYRE THERAPEUTICS, INC.Listing on record | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
GYRE THERAPEUTICS, INC.Listing on record | Exercise | $80 | SEC | ||
INTERCELL USA, INC.Listing unverified | Buy | $5M | conv 57ClusterUnusual size | SEC | |
VONAGE HOLDINGS CORPListing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
VONAGE HOLDINGS CORPListing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
VONAGE HOLDINGS CORPListing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
VONAGE HOLDINGS CORPListing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
VONAGE HOLDINGS CORPListing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
VONAGE HOLDINGS CORPListing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
VONAGE HOLDINGS CORPListing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
VONAGE HOLDINGS CORPListing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
VONAGE HOLDINGS CORPListing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
VONAGE HOLDINGS CORPListing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
VONAGE HOLDINGS CORPListing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
VONAGE HOLDINGS CORPListing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Paratek Pharmaceuticals, Inc.Listing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Paratek Pharmaceuticals, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
Paratek Pharmaceuticals, Inc.Listing unverified | Buy | $7.5M | conv 60ClusterUnusual size | SEC | |
Paratek Pharmaceuticals, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
Paratek Pharmaceuticals, Inc.Listing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
GYRE THERAPEUTICS, INC.Listing on record | OtherD (derivative) | $24.5M | SEC | ||
GYRE THERAPEUTICS, INC.Listing on record | Other | n/a (No price was disclosed in the filing) | SEC | ||
GYRE THERAPEUTICS, INC.Listing on record | Buy | $3.2M | conv 63ClusterUnusual size | SEC | |
OCCAM NETWORKS INC/DEListing unverified | Sell | $362.1K | Unusual size | SEC | |
OCCAM NETWORKS INC/DEListing unverified | Sell | $1.7M | Unusual size | SEC |